The Anglo-Swedish drugmaker is making a lot less than its competitors but that could soon change.In an upbeat earnings report today (April 30), Anglo-Swedish drugmaker AstraZeneca reported $275 million in revenue from its Covid-19 vaccine in the first three months of the year.The vaccine, known as ...

https://qz.com/2003736/how-much-money-is-astrazeneca-making-from-its-covid-vaccine/

#Quartz